Liver fibrosis improved upon administration of OM, as assessed by reduced deposition of collagen and reduced expression of genes co-occurring with liver fibrosis, such as MMP-2, TIMP-1, and type I procollagen (Chai et al., 2012). The gene discussed is TIMP1; the disease is Hepatic fibrosis.